MIM Software Inc. Announces AI Segmentation and Single Timepoint Dosimetry Capabilities for Molecular Radiotherapy


MIM Software Inc., a leading global provider of medical imaging software, announced today new innovations to MIM SurePlan™ MRT, its software package for Molecular Radiotherapy.

MIM SurePlan MRT has received CE Mark approval for new artificial intelligence (AI) segmentation models, which simplify the contouring process for dosimetry. AI segmentation provides significant time savings and enhanced results compared to manual and atlas-based segmentation.

In addition to these new AI segmentation models, MIM SurePlan MRT now includes two single timepoint methods – the Hänscheid approach and the prior-information approach.

Read More

Next Post

Bristol Hospital and Health Care Group, Inc.

Founded in 1921, Bristol Health is the leading health provider for people who live and work in the greater Bristol area. Proud of its achievements in service excellence, Bristol Health has earned national recognition for its commitment to providing outstanding patient care. Bristol Hospital has 154 licensed beds and offers […]